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The mechanism of energy converting NADH:ubiquinone oxidoreductase (complex I) is still unknown. A current controversy centers around
the question whether electron transport of complex I is always linked to vectorial proton translocation or whether in some organisms the enzyme
pumps sodium ions instead. To develop better experimental tools to elucidate its mechanism, we have reconstituted the affinity purified enzyme
into proteoliposomes and monitored the generation of ΔpH and Δψ. We tested several detergents to solubilize the asolectin used for liposome
formation. Tightly coupled proteoliposomes containing highly active complex I were obtained by detergent removal with BioBeads after total
solubilization of the phospholipids with n-octyl-β-D-glucopyranoside. We have used dyes to monitor the formation of the two components of the
proton motive force,ΔpH and Δψ, across the liposomal membrane, and analyzed the effects of inhibitors, uncouplers and ionophores on this
process. We show that electron transfer of complex I of the lower eukaryote Y. lipolytica is clearly linked to proton translocation. While this study
was not specifically designed to demonstrate possible additional sodium translocating properties of complex I, we did not find indications for
primary or secondary Na+ translocation by Y. lipolytica complex I.
© 2005 Elsevier B.V. All rights reserved.Keywords: Mitochondria; Complex I; Reconstitution; H+-pumping; Yarrowia lipolytica1. Introduction
NADH:ubiquinone oxidoreductase (complex I) is in most
organisms the first multiprotein complex in oxidative
phosphorylation of the bacterial cytoplasma membrane and the
mitochondrial inner membrane. Despite its central role in the
generation of the protonmotive forceΔp and the discovery of an
increasing number of human diseases linked to this enzyme,
neither its molecular structure nor the mechanism by which
electron transfer is coupled to proton translocation across the
inner mitochondrial membrane are known (for a recent review,Abbreviations: ACMA, 9-amino-6-chloro-2-methoxyacridine; DBQ, n-
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doi:10.1016/j.bbabio.2005.10.001see [1]). This is in part due to the complexity of mitochondrial
complex I comprising 46 subunits in bovine heart [2] and at
least 37 subunits in fungi [3]. A number of hypothetical
mechanisms have been proposed how complex I might pump
protons (see [4] for a review). The idea that iron–sulfur cluster
N2 may be a critical part of the proton pump [4–6] and the
observation of several different semiquinone species [7] has
stimulated proposals [4,8], that are based on the reversal of the
protonmotive Q-cycle operating in the cytochrome bc1 complex
(see [9] for a review). However, recent findings [1,10–12]
rather favour a conformational mechanism of proton pumping.
A pumping mechanism that operates by redox linked
conformational changes has been put forward already some
years ago [13].
A major obstacle towards the elucidation of the proton
pumping mechanism of complex I has been that experimental
systems suitable to analyze this process are scarce. For
mitochondrial complex I, proton-translocation has been
measured only in isolated rat liver mitochondria [14] and
Fig. 1. Specific activities of complex I after reconstitution with different
detergents. Proteoliposomes were prepared using ‘onset’ (open columns) or
‘total’ conditions (grey columns) and specific NADH:ubiquinone oxido-
reductase activities of FCCP-uncoupled proteoliposomes were measured in 20
mMK+-Mops, 50 mMKCl, pH 7.4 as detailed in Materials and methods. For the
calculation of the specific activities, the complex I recovery and the percentage
of inside-out oriented pumps were taken into account.
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both studies, a H+/2e− stoichiometry of 4 was determined.
Translocation of protons by the prokaryotic enzyme has been
reported for different species including Paracoccus denitrificans
[16], Escherichia coli [17] and Rhodobacter capsulatus [18].
Only recently, it has been shown that purified and reconstituted
complex from E. coli pumps protons [19]. However, in a similar
system, it was reported that complex I of the closely related
enterobacterium Klebsiella pneumoniae pumps sodium ions
rather than protons [20,21], a claim that has now been challenged
by other authors [22].
In recent years, we have developed the strictly aerobic yeast
Yarrowia lipolytica as a powerful tool to analyze the structure
and function of mitochondrial complex I. A large number of
functional mutations have already been generated in this
organism [23–26]. We have shown previously that purified Y.
lipolytica complex I can be reactivated by the addition of
phospholipids [27] and that after reconstitution into proteo-
liposomes, ubiquinone reductase activity can be stimulated by
the addition of uncoupler [28]. In this study, we have analyzed
how variation of the reconstitution protocol affects the
functional properties of complex I proteoliposomes and
demonstrate that electron transfer of complex I from a lower
eukaryote is linked to the generation of a proton motive force.
2. Material and methods
2.1. Materials
Asolectin (=total soy bean extract with 20% lecithin) was purchased from
Avanti Polar Lipids (Alabaster, AL). n-lauryl-β-D-maltoside was obtained from
Glycon (Luckenwalde, Germany) and octyl-β-D-glucopyranoside from
BIOMOL (Hamburg, Germany). 9-amino-6-chloro-2-methoxyacridine (ACMA)
and Oxonol VI (bis-(3-propyl-5-oxoisoxazol-4-yl) pentamethine Oxonol) were
purchased from Molecular Probes Europe (Leiden, The Netherlands). Chelating
Sepharose was from Pharmacia. The ionophores valinomycin, nigericin
(Antibiotic K 178), monensin, ETH 157 (sodium ionophore II) and FCCP and all
other detergents and chemicals were from Sigma. ACMA and Oxonol VI
were dissolved in dimethylsulfoxide; ubiquinone derivatives, inhibitors and
ionophores in ethanol.
2.2. Analytical methods
Protein concentrations were determined according to a modified Lowry
protocol [29]. Phospholipid content of purified complex I was determined as
total organic phosphate following a procedure described previously [27].Table 1
Effect of solubilization method on proteoliposome formation
Complex I recovery a (%) Inside-out a % RCRa, b
Onset 46–57 70–100 1.7–2.2
Total 49–60 40–65 3.1–5.8 c
a The range reflects the values obtained with different detergents
(octylglucoside, Triton X-100, C12E8, laurylmaltoside) that were used to
solubilize asolectin. The protein to phospholipids ratio was 1:50 (w/w)
throughout.
b No respiratory control ratios (RCR) were obtained for C12E8. See text for
details.
c These values were determined with different batches of proteoliposomes
made with one representative complex I preparation. In some measurements
with another preparation, even higher RCRs were observed (see Fig. 2).2.3. Yeast growth and preparation of mitochondrial membranes
Y. lipolytica strain PIPO [30] was grown overnight at 27 °C in a 10-l Biostat
E fermenter (Braun, Melsungen) in modified YPD medium (2.5% glucose, 2%
bactopeptone, 1% yeast extract). This strain contains a chromosomal copy
(introduced by homologous recombination with plasmid pNK1.2 as described in
[28]) of the modified NUGM gene, encoding a C-terminally his-tagged version
of the 30-kDa subunit. Mitochondrial membranes from strain PIPO were
prepared following the protocol of [31] with the modification detailed in [28].
2.4. Purification of complex I
Complex I was purified from Y. lipolytica strain PIPO as published
previously [28] with one minor modification: the imidazole concentration of the
buffer used for the equilibration and washing of the Ni2+–NTA column was
reduced to 55 mM. The combined complex I containing peak fractions of the gel
filtration (TSKgel 4000SW) were concentrated to 7–10 mg/ml by centrifugation
through Vivaspin cartridges (MWCO 100,000; Vivascience, UK) and stored in
liquid nitrogen.
2.5. Complex I proteoliposomes
Optimal conditions for the reconstitution of complex I were evaluated
following a guideline detailed by Rigaud and coworkers [32]. In general,
variations included the detergents used for solubilization of phospholipids,
protein-to-lipid-ratios, state of phospholipid solubilization and other factors
affecting detergent-removal (temperature, addition of Bio-Beads see below). For
an empirical approach, preformed liposomes were generated: asolectin obtained
as a solution in chloroform was placed into glass vials and the solvent was
evaporated under a constant stream of argon. Traces of chloroform were
removed under vacuum. The phospholipids were finally dissolved to a
concentration of 10 mg/ml in buffer containing 1.6% OG (w/v). This detergent
concentration was usually sufficient to solubilize the phospholipids completely.
If this was not achieved (as judged by turbidity), further OG was added until the
solution became clear. The OG-solubilized phospholipids were placed into
dialysis tubes and were dialyzed against 100 volumes of the respective buffer at
4 °C. After 4 h, the buffer was exchanged and dialysis was continued over night.
Fig. 2. Effect of lipid-to-protein ratio used for reconstitution on the magnitude of ACMA-quenching. Complex I was reconstituted using OG-total solubilized
phospholipids at protein-to-lipid-ratios of 1:33, 1: 67, 1:133 and 1:267 (w/w). The specific activities were 2.9, 4.9, 3.1 and 2.6 μmol·min−1·mg−1 and the coupling
factors were 5.1, 9.2, 7.4 and 8.3 for these batches of proteoliposomes. Proteoliposomes were added at approximately the same amount of phospholipids in each
measurement and the ACMA quenching was monitored as detailed under Materials and methods. 1 μM of DQAwas added to inhibit complex I.
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further use (solubilization experiments or reconstitution), the preformed
liposomes were pushed 19 times through polycarbonate membranes (pore size
200 nm) using a LiposoFast extruder (Avestin, Ottawa, Canada). Liposome
solubilization using different detergents (OG, LM, Triton X-100, Na-cholate,
C12E8) was monitored by measuring the optical density of the liposome-
containing solution at 450 nm, thereby determining the ‘onset’ and ‘total’
solubilization conditions [32]. Detergent was added stepwise in small quantities
to the liposome solution and the sample was stirred for 10 min before measuring
the absorption.
For the reconstitution of complex I, preformed liposomes were solubilized
by an amount of different detergents (OG, DDM, TX-100, Na-cholate, C12E8)
that was just sufficient to result in an absorbance change at 450 nm (‘onset’), or
that resulted in a maximal absorbance change indicating complete solubilization
(‘total’). In some experiments at ‘total solubilization’, preparation of preformed
liposomes was omitted and the phospholipid was directly dissolved in the
respective detergent. Purified complex I (usually 100–200 μg) was added at a
protein-to-lipid ratio of 1:50 (w/w) if not indicated otherwise. The detergents
were removed by BioBeads SM2 (pretreated according to [33]), following the
guidelines detailed by Rigaud and coworkers. As a standard procedure,
detergents were removed at room temperature by the addition of a 20-fold excess
of Bio Beads (by weight) that was applied stepwise as four equal aliquots in 1
h intervals. The Na+ and K+ concentration was checked in representative batches
of proteoliposomes in a Roche Modular Analytics ISE900 analyzer. The readout
was calibrated using standard solutions of NaCl and KCl in ultrapure water from
Merck (Darmstadt, Germany).2.6. Measurement of catalytic activity
NADH:HAR activity of purified and reconstituted complex I was measured
at 30 °C in the same buffer that had been used for reconstitution (usually 20 mM
K+/Mops, 50 mM KCl, pH 7.4; in some experiments as indicated 20 mM Na+/
Mops, 50 mM NaCl, pH 7.4) using 2 mM HAR and 200 μM NADH as
substrates. The fraction of inside-out oriented complexes (NADH binding site
outside) and the total yield of reconstituted complex I was estimated based on
the NADH:HAR activities before and after resolubilization of the
proteoliposomes with 0.5 mM Na-cholate.
For the determination of NADH:ubiquinone oxidoreductase activity 100 μM
DBQ (n-decylubiquinone) and 100 μM NADH were used as substrates,
following the protocol described previously [34]. Measurements were done in
the buffer that had been used during the reconstitution procedure. NADH-oxidation rates were recorded using a Shimadzu Multi Spec-1501 diode array
spectrophotometer (ε340–400 nm=6.1 mM
−1 cm−1). The respiratory control ratio
(RCR) of the proteoliposomes was determined as the ratio of NADH:DBQ
activity of the reconstituted complex I in the presence and absence of 5 μM
FCCP.
2.7. Measurement of proton gradient
Proteoliposomes containing 5–10 μg of complex I were added to 2 ml buffer
(20 mM K+/Mops pH 7.2, 50 mM KCl, 5 μM valinomycin if not stated
otherwise) in a stirred cuvette. H+-translocation was monitored as fluorescence
change of ACMA that was added to a final concentration of 0.5 μM.
Measurements were performed in a Shimadzu RF-5001 fluorimeter at an
excitation wavelength of 430 nm and an emission wavelength of 475 nm (band
pass 5 nm each, integration time 1 s). The reaction was started by the successive
addition of DBQ (or Q-1) and NADH.
2.8. Measurement of the membrane potential
The generation of a membrane potential was recorded by measuring the
absorption changes (623–604 nm) of the potential-sensitive dye Oxonol VI
(2 μM) with a Shimadzu MultiSpec diode array spectrophotometer in a
stirred 1 ml cuvette. Since a diode array spectrophotometer was used,
NADH oxidation could be followed in parallel as absorbance change at 340
nm minus 400 nm. As in the case of the activity measurements, the
experiments were performed in same buffer that had been used during
reconstitution, i.e., K+-containing proteoliposomes were added to 20 mM K+/
Mops pH 7.2, 50 mM KCl and Na+-containing proteoliposomes to 20 mM
Na+/Mops pH 7.2, 50 mM NaCl.
3. Results
3.1. Properties of complex I proteoliposomes
As a general approach, purified complex I from Y. lipolytica
was added to detergent solubilized lipids or preformed
liposomes. Proteoliposomes were formed by incubation with a
large excess of BioBeads for several hours that removed the
detergent molecules from the phospholipid detergent mixtures
Fig. 3. Proton pumping of reconstituted complex I. Purified complex I (NADH:
HAR activity 39.1 μmol·min−1·mg−1) was reconstituted as detailed in Materials
and Methods using OG-total solubilized asolectin at protein-to-lipid-ratios of
1:50. Uncoupled NADH:DBQ activity was 4.1 μmol·min−1·mg−1 and
uncoupled NADH:Q1 activity was 4.8 μmol·min
−1·mg−1. Respiratory control
ratios were 3.0 and 3.2, respectively. All measurements were done in presence of
50 mM KCl and 5 μM valinomycin with 9.8 μg of reconstituted complex I. 0.5
μM ACMA, 60 μM DBQ or Q1 and 100 μM NADH, 1 μM DQA, 12.5 μM
nigericin, 1 μM rotenone, 1 μMFCCPwere added as indicated. In panel F, 1 μM
DQAwas added before starting the measurement.
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liposomes were collected by ultracentrifugation. To study the
influence of the detergent to lipid ratio, lipid–detergents mixtures
were prepared either with an amount of detergent just sufficient to
destabilize the preformed liposomes (‘onset’ condition) or to
completely solubilize the lipid (‘total’ condition, [32]). The
appropriate amounts of the different detergents used were
determined for every batch of preformed liposomes to account
for variations and heterogeneity of the asolectin used. As judged
by the NADH:HAR oxidoreductase activity following resolu-
bilization of the liposomes with Na-cholate, the overall recovery
of complex I was in the range of 45–60% and did not depend
markedly on the detergent or solubilization method used (Table
1). Losses of complex I varied considerably from batch to
batch and were likely due to binding of the protein to the Bio
Beads.
The fraction of incorporated complex I that was accessible
in intact proteoliposomes for its hydrophilic substrate NADH
reflected the portion of enzyme that had been incorporated in
‘inside-out’ orientation with respect to intact mitochondria.
Although this fraction varied considerably, the ‘inside-out’
orientation clearly was predominant if ‘onset’ conditions
were used (Table 1). In contrast, complex I was found to be
randomly oriented in the proteoliposomes, if ‘total’
conditions were applied. Although the type of detergent used
to solubilize the lipids seemed to have no major influence on
the orientation of complex I in the membrane, the fraction of
‘inside-out’ oriented complexes tended to be somewhat
higher if C12E8 or LM rather than OG or TX-100 were used
(data not shown). While ‘onset’ conditions seemed to result
in more favourably oriented proteoliposomes, ‘total’
conditions seemed to result in tighter sealed membranes: this
was evident from the significantly higher respiratory control
ratios that were observed when the lipids were completely
solubilized prior to the addition of complex I. Typically,
addition of the uncoupler FCCP to proteoliposomes prepared
using ‘total’ conditions resulted in a 3-6 fold increase in
NADH:ubiquinone oxidoreductase activity. In contrast, this
rate was only roughly doubled when the proteoliposomes
had been prepared by the ‘onset’ protocol (Table 1). Also
respiratory control ratios were hardly affected by the
detergent used to solubilize the lipids. When lower protein
to lipid ratios were used, even higher respiratory control
ratios were obtained (see below). Only when C12E8 was
used, rather low electron transfer activities (Fig. 1) that
exhibited no respiratory control were observed. This
indicated that significant amounts of this polyoxyethylene
detergent that is also known to act as a rather efficient
inhibitor of bovine complex I [35] were still bound to
complex I. In fact, we determined an I50 value for C12E8 of
about 10 μM for purified and relipidated complex I from Y.
lipolytica (data not shown). Remarkably, residual inhibition
was not observed with TX-100, the other polyoxyethylene
detergent used in this study that had been shown to inhibit
bovine complex I [36]. At around 400 μM, the I50 value for
TX-100 indicated a rather low affinity of this detergent for
Y. lipolytica complex I (data not shown). In fact, the highestspecific activities were observed when TX-100 was used to
solubilize the lipids (Fig. 1).
In contrast to other properties of complex I proteoli-
posomes, specific activities were essentially the same, no
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Using cholate and LM resulted in specific activities that were
only about half of those obtained with TX-100. With a specific
NADH:ubiqunone oxidoreductase activity of around 15
μmol·min−1·mg−1, proteoliposomes that had been prepared
using OG as a detergent exhibited about 75% of the rates
observed with TX-100. Despite of the higher activities
obtained with TX-100, we decided to use octylglucoside as a
detergent to completely avoid any specific interference of
residual detergent with the ubiquinone binding pocket ofFig. 4. Effect of K+/valinomycin and Na+/ETH157 on proton pumping of reconstitut
was reconstituted either in 1 mM Na+/Mops, 50 mM NaCl, pH 7.4 or 1 mM K+/Mo
ratios of 1:50. Uncoupled NADH:DBQ activity was 17.0 μmol·min−1·mg−1 in the K+
4.7 and 3.9, respectively. Measurements were done in the respective buffers (traces A a
DBQ, 100 μM NADH, 0,5 μM valinomycin, 1 μM nigericin, 1 μM monensin, 1 μ
comparable to valinomycin) ETH 157.complex I. As only the ‘inside-out’ oriented enzymes could
react with NADH and tightness of the liposomal membranes is
the more important parameter when measuring proton
translocation, proteoliposomes were routinely prepared using
octylglucoside and ‘total’ conditions for all subsequent
experiments. No specific efforts were made to remove sodium-
ions from the proteoliposomes, but Na+ determinations in
representative batches revealed that the Na+ concentration was
well below 0.3 mM when the proteoliposomes were prepared
in 50 mM KCl.ed complex I. Purified complex I (NADH:HAR activity 65,5 μmol·min−1·mg−1)
ps, 50 mM KCl, pH 7.4 using OG-total solubilized asolectin at protein-to-lipid-
-buffer and 12.5 μmol·min−1·mg−1 in Na+-buffer. Respiratory control ratios were
nd B: K+-buffer; traces C and D: Na+-buffer). Additions: 0.5 μMACMA, 60 μM
M FCCP, 1 μM (trace C) or 5 μM (trace D, to ensure a fast collapse of ΔΨ,
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To monitor proton pumping of reconstituted Y. lipolytica
complex I, we followed the fluorescence change of ACMA. Its
fluorescence is quenched upon formation of a pH-gradient
across the liposomal membrane due to redistribution of the dye
following acidification of the vesicle lumen [37]. Valinomycin
was added to complex I proteoliposomes prior to the start of the
measurements to prevent formation of a membrane potential.
When NADH and the ubiquinone-derivative DBQ were
added to liposomes previously loaded with ACMA, some of the
fluorescence was quenched due to absorption by spectral
overlap (Fig. 2). This immediate fluorescence change was
followed by a further decrease in fluorescence reflecting
pumping of H+ by complex I into the lumen of the
proteoliposomes. The signal reached a steady state plateau
where the rate of proton pumping, which is controlled by the
ΔμH+ across the membrane, was compensated by the proton
leak rate of the liposomal membrane. The ACMA quenching
was clearly due to the build-up of a ΔμH+ and not due to the
consumption of ‘scalar’ protons during the oxidation of NADH
(NADH+H+→NAD+). Even when 100 μM NaOH were
added, no change in ACMA fluorescence was observed because
of the high outside buffer capacity used in the experiments (not
shown). Both, the rate at which the ACMA fluorescence wasFig. 5. Generation of Δψ by reconstituted complex I in the presence of potassium ion
and the NADH oxidation (340–400 nm) were recorded simultaneously with a Shim
methods. Proteoliposomes were reconstituted in 20 mMK+/Mops, 50 mMKCl with O
μg protein) were diluted in 1 ml of the same buffer. Substrates/effectors were added as
μMDBQ, 5 μM valinomycin (Val), 1 μMDQA. Note, that the respiratory control rati
in Table 1. This can be explained by the partial uncoupling effect of the dye oxonoquenched and the level of the steady state plateau was strictly
dependent on protein load of the liposomes (Fig. 2): At a protein
to lipid ratio of 1:33 more than 90% of the total fluorescence
was quenched within about 30 s, while at a ratio of 1:267 the
maximal quench was only about 60% and was reached only
after about 2 min. This suggested that despite the higher
respiratory control ratio the smaller number of complex I
molecules per vesicle was not sufficient to maintain a maximal
steady-state proton gradient. The ACMA quench was rapidly
abolished by the addition of the complex I inhibitors DQA or
rotenone (Figs. 2, 3, traces A and B). Virtually identical results
were obtained when Q-1, a ubiquinone derivative carrying a
single isoprenoid group as a sidechain, was used as a substrate
(Fig. 3, trace C). The proton gradient could also be collapsed by
the addition of the H+/K+ antiporter nigericin or the uncoupler
FCCP (Fig. 3, traces D and E). If the inhibitor DQAwas added
before the substrate, electron transfer did not result in a
fluorescence quench and subsequent addition of uncoupler had
no effect (Fig. 3, trace F). If valinomycin was omitted from the
experiment, the magnitude of the ACMA quenching was lower
and increased if the potassium ionophore was added
subsequently (Fig. 4, traces A and B). These results clearly
demonstrated that the substrate induced ACMA fluorescence
quench indicated the formation of a proton gradient due to
proton pumping by complex I. A very similar set of data wass. Absorbance changes (623–604 nm) of the potential-sensitive dye Oxonol VI
adzu MultiSpec diode array spectrophotometer as detailed under Materials and
G-total solubilized asolectin. For each measurement, proteoliposomes (approx. 5
indicated at the following concentrations: 2 μMOxonol VI, 100 μMNADH, 100
os that can be deduced from the traces are somewhat lower than the values given
l VI.
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reconstitution and proton translocation measurements except
that the potassium-specific ionophore valinomycin was
replaced by the sodium ionophore ETH 157 (Fig. 4). A
somewhat lower NADH:ubiquinone oxidoreductase activity
was the only significant difference observed if potassium was
replaced by sodium and ACMA quenching in the absence of
ionophores was less pronounced. Importantly, the sodium
ionophore ETH 157 had the same effect on Na+-loaded
proteoliposomes as valinomycin on K+-loaded proteoliposomes
(Fig. 4 traces C and D): ΔpH increased due to the collapse of
ΔΨ. If Na+ would be transported by complex I, and the
observed ΔpH would be only secondary, one would have
expected a decrease following addition of ETH 157.
3.3. Generation of Δψ by reconstituted complex I
The generation of a membrane potential (inside positive) was
monitored using the potential-sensitive dye Oxonol VI. In
tightly coupled proteoliposomes or submitochondrial particles,
a red shift of the absorption spectrum of this dye occurs in
response to a positive-inside membrane potential [38]. When
complex I turnover was started by the addition of DBQ and
NADH to the proteoliposomes (Fig. 5 top), an increase of
Oxonol VI absorption at 623 minus 604 nm was detected (Fig. 5
bottom) indicating the build-up of a membrane potential. The
increase in Oxonol VI absorption leveled off after about 20 s,
suggesting that–as in the ACMA fluorescence quenchFig. 6. Generation of Δψ by reconstituted complex I in the presence of sodium ion
experiments, complex I was reconstituted in 20 mM Na+/Mops, 50 mM NaCl with
Na+/Mops buffer. Substrates/effectors were added as indicated at the following con
μM monensin (Mon).experiments– formation of the gradient was limited by the
proton leak. Consistently, FCCP induced a rapid collapse of the
membrane potential by uncoupling (not shown). Addition of the
ionophore valinomycin (in presence of K+) resulted in a rapid
collapse of the membrane potential, but asΔψ but notΔpH was
dissipated, the rate of electron transfer monitored by the
absorption change at 340–400 nm was hardly affected (Fig. 5
left panel). Addition of the complex I inhibitor DQA blocked
electron transfer and, due to the proton leak of the
proteoliposomes, resulted in the dissipation of the membrane
potential (Fig. 5 right panel).
Again, rather similar results were obtained if potassium ions
were exchanged by sodium ions during reconstitution and
Oxonol VI measurements. The membrane potential generated
by complex I turnover was sensitive to uncoupling by the
protonophore FCCP. Abolishing the proton motive force
completely resulted in an increase in the electron transfer rate.
On the other hand, no effect on the electron transfer rate was
observed following addition of the H+/Na+ antiporter monensin
and even a transient increase of the positive inside membrane
potential was observed (Fig. 6). This demonstrated that the
turnover of reconstituted complex I was linked to the formation
of primary proton gradient.
4. Discussion
Functional reconstitution of purified complex I in well
coupled proteoliposomes is prerequisite to study the still elusives. The general conditions were as indicated in the legend of Fig. 5. For these
OG-total solubilized asolectin. Measurements were performed in the identical
centrations: 2 μM Oxonol VI, 100 μM NADH, 100 μM DBQ, 1 μM FCCP, 1
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We found that both the nature and amount of the detergent used
to solubilize the phospholipids had marked effect on the
properties of complex I proteoliposomes that were formed upon
removal of the detergent with BioBeads. Proteoliposomes best
suited for functional studies were obtained when the
phospholipids were solubilized completely with octylglucoside
resulting in highly active and well coupled complex I
liposomes. Specific ubiquinone reductase activity was found to
be highest when TX-100 was used for solubilization, but this
detergent, as well as C12E8, the other polyoxyethylene detergent
used, were found to act as inhibitors of Yarrowia complex I. As
inhibition was observed with C12E8, the presence of residual
inhibitory detergent in the proteoliposomes could also not be
completely excluded for the weaker binding TX-100. Clearly,
the well-coupled proteoliposomes that contain highly active
complex I will be suited to measure proton to electron
stoichiometries of wild-type and mutant enzyme in future
studies.
So far, proton-translocation by mitochondrial complex I was
only demonstrated directly in isolated rat liver mitochondria
[14], submitochondrial particles derived from bovine heart [15]
and bovine heart complex I reconstituted into proteoliposomes
[39]. Here, we show that reconstitution of highly pure
mitochondrial complex I from the yeast Y. lipolytica into
proteoliposomes resulted in fully functional and inhibitor
sensitive electron transfer activity that was linked to vectorial
H+-translocation. In agreement with the findings of Ragan and
Hinkle [39], we observed that also reconstituted complex I from
Y. lipolytica is only completely ‘uncoupled’ (as judged by the
collapse of the ΔpH or by the stimulation of the NADH:DBQ
activity) if ionophores that dissipate both components of the
proton-motive-force (either FCCP or the combination of
valinomycin and nigericin in K+-containing buffer or ETH 157
and monensin in Na+-containing buffer) are present. The ΔΨ-
dissipating ionophores valinomycin or ETH 157 alone had no
effect.
It has been reported that reconstituted complex I (NDH I)
from the enterobacteria Klebsiella pneumonia [20,21] and
Escherichia coli [40,41] exclusively pumps Na+-ions rather
than protons. This claim has been challenged by other authors
for both organisms [19,22]. Thus, it remains unclear which ions
are pumped by prokaryotic complex I. Our results analyzing the
effects of different uncouplers and ionophores on ΔpH and Δψ
generated by mitochondrial complex I unequivocally demon-
strate that the enzyme from Y. lipolytica is a primary proton
pump. With respect to the possibility that complex I from Y.
lipolytica may in addition act as a Na+ pump, it should be noted
that rather than being stimulated NADH:DBQ oxidoreductase
activity was found to be consistently lower in the presence of 50
mM Na+ than in the presence of 50 mM K+. Although we have
made no efforts to remove sodium ions from the
proteoliposomes, the Na+ concentration in the proteoliposomes
prepared with 50 mM KCl was found to be well in the
submillimolar range. As the apparent Km for the stimulatory
effect on the activity of complex I from K. pneumonia was
reported to be around 4 mM [42] we would have rather expectedhigher activities in the presence of 50 mM NaCl. Moreover,
the effects of valinomycin in the presence of potassium ions
and ETH157 in the presence of sodiums ions on the proton
pumping activity were essentially the same (Fig. 4). Finally,
adding the Na+/H+ antiporter monensin in presence of sodium
ions caused a small increase (Fig. 5) which seems to rule out
that complex I itself acts as a potent H+/Na+ antiporter.
Overall, there were no indications suggesting that complex I
functioned as a primary sodium pump or exhibited H+/Na+
antiporter activity.Acknowledgements
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